Introduction: Experimental animal studies provided evidence for a synergistic effect of immunological and psychological stressors on subsequent sickness behaviours. Up to now, little corroborating evidence for such synergy exists for humans, in whom it may provide a mechanism leading to the expression of functional somatic symptoms. The aim of the present study was to determine an interaction between stress(-vulnerability) and an immunological activation on experimental pain sensitivity, i.e., pressure pain threshold and tolerance in healthy humans. Methods: In healthy female participants (n = 25, mean age 22.3 years), negative affectivity (NA) and experienced stress were assessed by questionnaire before receiving a Salmonella typhi vaccine or saline control in a randomized blinded cross-over design. Pressure pain threshold was assessed at the lower back and calves and pain tolerance was assessed at the thumbnail, before and six hours after each injection. Results: Vaccination induced leukocytosis (+100%) and increased serum IL-6 (+670%). NA predicted decreased pain tolerance after vaccination (b = À.57, p = .007), but not after placebo (b = .25, p = .26). Post-hoc analyses also demonstrated an association with administration order. Discussion: NA moderated the effects of inflammation on pain tolerance. This finding is consistent with a synergistic model whereby inflammation may lower the threshold for pain reporting in individuals with increased vulnerability for somatic symptom reporting.
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Introduction
In reaction to an immunological challenge, immune-to-brain communication leads to a constellation of reversible behavioural and affective changes, denoted as sickness behaviour (Hart, 1988; Kent et al., 1992) . These include lethargy, social withdrawal, and enhanced sensitivity to pain (Larson and Dunn, 2001; Yirmiya et al., 1994) . Animal studies have demonstrated that (psychological) stress factors may sensitize this immune-to-brain communication, resulting in a prolonged or more severe expression of sickness behaviour symptoms when an immunological stressor is applied (Anisman et al., 2007; Gibb et al., 2013) . Sensitization for sickness behaviours may thus entail dual involvement of immunological and psychological factors.
Such synergism might be applicable to humans as a possible explanatory mechanism for the experience of somatic symptoms or syndromes that cannot be fully explained by a present medical
